KCNQ2 Gene Seizures Benign Neonatal Type 1 NGS Genetic DNA Test
Introduction to the KCNQ2 Gene Seizures Test
The KCNQ2 Gene Seizures Benign Neonatal Type 1 NGS Genetic DNA Test is a pivotal diagnostic tool designed to identify genetic mutations associated with benign neonatal seizures. This test employs advanced next-generation sequencing (NGS) technology to analyze the KCNQ2 gene, which plays a crucial role in regulating neuronal excitability. Understanding these genetic factors is vital for early diagnosis and management of neurological disorders in newborns.
What the Test Measures
This test specifically detects mutations in the KCNQ2 gene that may contribute to the occurrence of seizures in neonates. By analyzing the genetic material, the test provides insights into the likelihood of developing neurological conditions associated with this gene.
Who Should Consider This Test?
Parents or guardians should consider this test if:
- There is a family history of seizures or neurological disorders.
- The newborn has exhibited symptoms of seizures.
- Genetic counseling has indicated a potential risk for KCNQ2-related conditions.
Benefits of Taking the Test
Taking the KCNQ2 Gene Seizures test offers several benefits:
- Early diagnosis of potential neurological disorders.
- Informed decision-making regarding treatment options.
- Family planning and understanding of genetic risks.
- Access to specialized care and monitoring for affected individuals.
Understanding Your Results
Results from the KCNQ2 Gene Seizures test will provide insights into the presence of genetic mutations. A genetic counseling session is recommended to help interpret the results and understand their implications for the patient and family. Your healthcare provider will guide you through the next steps based on the findings.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| KCNQ2 Gene Seizures Benign Neonatal Type 1 NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Branches and Booking
We have branches across all major cities in Kenya, making it convenient for you to access our services. Additionally, we offer home sample collection services for your convenience. To book the KCNQ2 Gene Seizures test, please call or WhatsApp us at +254746849631. Take the first step towards understanding your child’s health today!
Additional Information
Turnaround time for results is typically between 3 to 4 weeks. The sample type required for this test can be blood, extracted DNA, or one drop of blood on an FTA card. Prior to testing, a clinical history of the patient and a genetic counseling session to draw a pedigree chart of family members affected with KCNQ2 Gene Seizures is essential.
Consultation with a neurologist or genetics specialist is recommended for those considering this test, ensuring comprehensive care and support.
